Literature DB >> 11280744

Heterogeneous nuclear ribonucleoprotein B1 as early cancer biomarker for occult cancer of human lungs and bronchial dysplasia.

E Sueoka1, N Sueoka, Y Goto, S Matsuyama, H Nishimura, M Sato, S Fujimura, H Chiba, H Fujiki.   

Abstract

Heterogeneous nuclear ribonucleoprotein (hnRNP) B1 is a RNA-binding protein of Mr 37,000. We previously reported that hnRNP B1 was specifically overexpressed in the nuclei of human lung cancer cells, particularly in squamous cell carcinoma (E. Sueoka et al., Cancer Res., 59: 1404-1407, 1999). We extended this study to determine whether hnRNP BL was overexpressed in roentgenographically occult cancers of the lungs and premalignant lesions of squamous cell carcinomas, such as bronchial dysplasia. The additional object of our study was to examine the usefulness of hnRNP B1 as a potential diagnostic marker for squamous cell carcinoma of various organs, such as the oral cavity and esophagus in humans. Surgically resected specimens of bronchial dysplasia, lung cancers, and various human squamous cell carcinomas, collected at two hospitals in Japan, were subjected to immunohistochemical staining with anti-hnRNP B1 antibody. Overexpression of hnRNP B1 protein was observed in 100% of stage I lung cancer tissues, but it was not found in normal bronchial epithelium. Squamous cell carcinoma of the lungs showed stronger staining than other histological types, and elevation of hnRNP B1 was found in both roentgenographically occult lung cancers and bronchial dysplasia. Furthermore, cytological examination with anti-hnRNP B1 antibody detected cancer cells in sputum, suggesting the potential of hnRNP B1 protein as a new biomarker for the very early stage of lung cancer in humans. Because strong staining of hnRNP B1 was also observed in various squamous cell carcinomas of oral and esophageal tissues as shown in our recent reports, overexpression of hnRNP B1 seems to be a common event in the carcinogenic processes of squamous cell carcinoma. These results suggest that hnRNP B1 protein could be a useful diagnostic biomarker for both the very early stages of lung cancer and various squamous cell carcinomas in humans.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11280744

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  19 in total

Review 1.  Sputum examination for early detection of lung cancer.

Authors:  F B J M Thunnissen
Journal:  J Clin Pathol       Date:  2003-11       Impact factor: 3.411

2.  Identification of cellular mRNA targets for RNA-binding protein Sam68.

Authors:  Michiyasu Itoh; Izumi Haga; Qing-Hua Li; Jun-ichi Fujisawa
Journal:  Nucleic Acids Res       Date:  2002-12-15       Impact factor: 16.971

3.  The emerging role of splicing factors in cancer.

Authors:  Ana Rita Grosso; Sandra Martins; Maria Carmo-Fonseca
Journal:  EMBO Rep       Date:  2008-10-10       Impact factor: 8.807

4.  Establishment of a new method, transcription-reverse transcription concerted reaction, for detection of plasma hnRNP B1 mRNA, a biomarker of lung cancer.

Authors:  Akemi Sato; Naoko Sueoka-Aragane; Juichi Saitoh; Kazutoshi Komiya; Takashi Hisatomi; Rika Tomimasu; Shinichiro Hayashi; Eisaburo Sueoka
Journal:  J Cancer Res Clin Oncol       Date:  2008-05-07       Impact factor: 4.553

5.  Comparison of osteopontin, beta-catenin and hnRNP B1 expression in lung carcinomas.

Authors:  Muhammet Emin Guldur; Yasemin Kibar; Hale Deniz; Kemal Bakir
Journal:  Pathol Oncol Res       Date:  2009-07-17       Impact factor: 3.201

6.  Protein and gene expression characteristics of heterogeneous nuclear ribonucleoprotein H1 in esophageal squamous cell carcinoma.

Authors:  Yu-Lin Sun; Fei Liu; Fang Liu; Xiao-Hang Zhao
Journal:  World J Gastroenterol       Date:  2016-08-28       Impact factor: 5.742

7.  Up-regulation and subcellular localization of hnRNP A2/B1 in the development of hepatocellular carcinoma.

Authors:  Huaqing Cui; Feng Wu; Yanling Sun; Guocai Fan; Qingming Wang
Journal:  BMC Cancer       Date:  2010-07-06       Impact factor: 4.430

Review 8.  Response of heterogeneous ribonuclear proteins (hnRNP) to ionising radiation and their involvement in DNA damage repair.

Authors:  Benjamin Haley; Tatjana Paunesku; Miroslava Protić; Gayle E Woloschak
Journal:  Int J Radiat Biol       Date:  2009-08       Impact factor: 2.694

9.  hnRNPA2/B1 activates cyclooxygenase-2 and promotes tumor growth in human lung cancers.

Authors:  Yang Xuan; Jingshu Wang; Liying Ban; Jian-Jun Lu; Canhui Yi; Zhenglin Li; Wendan Yu; Mei Li; Tingting Xu; Wenjing Yang; Zhipeng Tang; Ranran Tang; Xiangsheng Xiao; Songshu Meng; Yiming Chen; Quentin Liu; Wenlin Huang; Wei Guo; Xiaonan Cui; Wuguo Deng
Journal:  Mol Oncol       Date:  2015-11-30       Impact factor: 6.603

10.  Significantly increased antibody response to heterogeneous nuclear ribonucleoproteins in cerebrospinal fluid of multiple sclerosis patients but not in patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis.

Authors:  Motohiro Yukitake; Eisaburo Sueoka; Naoko Sueoka-Aragane; Akemi Sato; Hiromi Ohashi; Yusuke Yakushiji; Mineki Saito; Mitsuhiro Osame; Shuji Izumo; Yasuo Kuroda
Journal:  J Neurovirol       Date:  2008-04       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.